Who is sponsoring NCT05983913?

NCT05983913 is sponsored by Sahmyook University.

What drugs are being tested in NCT05983913?

Interventions in NCT05983913: cognitive-motor training, cognition training.

What condition does NCT05983913 study?

NCT05983913 studies Cognitive Decline, Mild, Cognition Disorders in Old Age, Subjective Memory Decline.

Is NCT05983913 still recruiting?

NCT05983913 is currently completed. Last updated 25 October 2023.

Last reviewed 2023-10-25 · How we verify

NCT05983913

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Wearable Sensor-based Interactive Cognitive-motor Training in Older Adults.

Completed NA Last updated 25 October 2023

What this trial tests

NA trial testing cognitive-motor training in Cognitive Decline, Mild in 40 participants. Completed in 15 October 2023.

Timeline

26 August 2023

Primary endpoint
15 October 2023

15 October 2023

Quick facts

Lead sponsor	Sahmyook University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	40
Start date	26 August 2023
Primary completion	15 October 2023
Estimated completion	15 October 2023
Sites	1 location across South Korea

Drugs / interventions tested

cognitive-motor training
cognition training

Conditions studied

Cognitive Decline, Mild — all drugs for Cognitive Decline, Mild →
Cognition Disorders in Old Age — all drugs for Cognition Disorders in Old Age →
Subjective Memory Decline — all drugs for Subjective Memory Decline →

Sponsor

Sahmyook University

Who can join

65 and older, any sex, with Cognitive Decline, Mild or Cognition Disorders in Old Age. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

* Based on research showing that cognitive-motor training programs help improve cognition in older adults with mild cognitive impairment, this program uses an interactive system to combine cognitive training with exercise. * The interactive system consists of wearable sensors and has the advantage of cognitive training without space constraints, and the cognitive training program consists of a total of five developed cognitive training games. * The program is expected to improve the cognitive abilities of the elderly and improve their physical abilities.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Enhancing cognitive and physical performance in older adults through wearable sensor-based interactive cognitive-motor training: a randomized clinical trial.
Jung J, Ryu HC, Lee S. · · 2025 · cited 1× · PMID 40437038 · DOI 10.1038/s41598-025-03725-x

Verify or expand the search:

Other trials of cognitive-motor training

Trials testing the same drug.

NCT07428837 — Effect of Cognitive-motor Training Versus Pilates Exercises on Postural Stability in Down Syndrome. · NA · recruiting

Other recruiting trials for Cognitive Decline, Mild

Currently open trials in the same condition.

NCT06495190 — Cognition, Flavonoids, Exercise, Gut Microbiome · NA · recruiting
NCT06362707 — Fasudil Trial for Treatment of Early Alzheimer's Disease (FEAD) · Phase 2 · recruiting

Other Sahmyook University trials

Trials by the same sponsor.

NCT07367646 — Development of Multidimensional Screening Tool for WMSDs · not yet recruiting
NCT07327541 — Cognitive, Physical, and Pain-Related Correlates in Community-Dwelling Older Adults · completed
NCT07278791 — Survey-Based Study on Recovery Period Differences in Upper Extremity Injuries Among Indoor Climbers by Treatment Method · not yet recruiting
NCT07138118 — Study of Blood Flow Restriction and Cognitive-Motor Dual Task Training to Improve Strength, Gait, and Balance in People · NA · completed
NCT07134829 — The Effects of Stroboscopic Visual Conditions on Gait and Lower Limb Muscle Activity in Individuals With Chronic Ankle I · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05983913 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sahmyook University
Last refreshed: 25 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05983913.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing